Heithem Soliman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Heithem Soliman has a total of 106 co-authors. Here are the top co-authors by number of shared publications:
- Guillaume Gourcerol
Univ Rouen Normandie, INSERM, Normandie Univ, ADEN UMR1073, Nutrition, Inflammation and microbiota-gut-brain axis, Rouen, France
7 shared publications Benoit Coffin
Département d'hépato-gastro-entérologie, hôpital Louis-Mourier, université Paris-Cité, AP-HP, 92700, Colombes, France
5 shared publicationsHenri Duboc
5 shared publications- Benoit Coffin
Department of Gastroenterology AP‐HP Nord Hôpital Louis Mourier Colombes France
4 shared publications Marie Dior
Assistance Publique- Hôpitaux de Paris, Service d'Hépato-Gastro-Entérologie, Hôpital Louis Mourier, DMU ESPRIT AP-HP Nord, Colombes F-92700, France
4 shared publicationsCharlotte Desprez
Department of Digestive Physiology ADEN UMR1073, Nutrition, Inflammation and Microbiota‐Gut‐Brain Axis, CHU Rouen, CIC‐CRB 1404, Univ Rouen Normandie, INSERM, Normandie Univ Rouen France
3 shared publications
Latest Publications
- Open Access
- 28 September 2026
- Published by Wiley in Comprehensive Physiology
- Vol. 16 (5) , e70275
Gastric Emptying in Obesity and Weight‐Loss Interventions: Physiology, Assessment, and Clinical Implications
Gastric emptying is a key determinant of digestion, appetite regulation, and metabolic homeostasis. Its assessment relies on several techniques, among which gastric emptying scintigraphy remains the reference standard owing to its physiological relevance and reproducibility when performed using standardized protocols. In current clinical practice, scintigraphy is mainly used for the diagnosis of gastroparesis and dumping syndrome, but in the field of obesity, it appears as a promising research and phenotyping tool. Although earlier studies in obesity reported heterogeneous results, larger cohorts and meta‐analyses now support an acceleration of gastric emptying in subjects with obesity, accompanied by increased gastric accommodation and alterations in gut hormone signaling. Most importantly, obesity treatments, including bariatric surgery, endoscopic bariatric procedures, and pharmacological therapies such as GLP‐1 receptor agonists, induce marked and procedure‐specific modifications in gastric emptying. These changes may contribute to their metabolic and weight‐loss effects. This narrative review summarizes the physiological mechanisms governing gastric emptying, provides an overview of current assessment methods with a focus on scintigraphy, and examines the impact of obesity and obesity treatments on gastric emptying, highlighting its relevance as a potential biomarker and therapeutic target.
- 28 September 2026
- Published by Wiley in Comprehensive Physiology
- Vol. 16 (5) , e70275
Open AccessGastric Emptying in Obesity and Weight‐Loss Interventions: Physiology, Assessment, and Clinical Implications
Gastric emptying is a key determinant of digestion, appetite regulation, and metabolic homeostasis. Its assessment relies on several techniques, among which gastric emptying scintigraphy remains the reference standard owing to its physiological relevance and reproducibility when performed using standardized protocols. In current clinical practice, scintigraphy is mainly used for the diagnosis of gastroparesis and dumping syndrome, but in the field of obesity, it appears as a promising research and phenotyping tool. Although earlier studies in obesity reported heterogeneous results, larger cohorts and meta‐analyses now support an acceleration of gastric emptying in subjects with obesity, accompanied by increased gastric accommodation and alterations in gut hormone signaling. Most importantly, obesity treatments, including bariatric surgery, endoscopic bariatric procedures, and pharmacological therapies such as GLP‐1 receptor agonists, induce marked and procedure‐specific modifications in gastric emptying. These changes may contribute to their metabolic and weight‐loss effects. This narrative review summarizes the physiological mechanisms governing gastric emptying, provides an overview of current assessment methods with a focus on scintigraphy, and examines the impact of obesity and obesity treatments on gastric emptying, highlighting its relevance as a potential biomarker and therapeutic target.
- 8 April 2026
- Published by Agence Bibliographique de l'Enseignement Supérieur
Apport de la manométrie antro-pyloro-duodénale haute résolution couplée à l'impédancemétrie dans la physiopathologie des syndromes dyspeptiques.
La manométrie antro-pyloro-duodénale en haute résolution (MAD-HR) permet une exploration fine des contractions gastro-intestinales et leur propagation. Son apport dans l’exploration des troubles moteurs et fonctionnels de la région gastro-duodénale, se manifestant par des syndromes dyspeptiques, a pourtant été peu évalué. Le 1e axe de ce travail s’est focalisé sur l’apport pronostique de la manométrie intestinale. Nous avons montré qu’une dysmotilité de l’intestin grêle était associée à une surmortalité, par rapport aux patients avec une manométrie normale avec un hazard ratio de 2.60 [1.29–6.89] indépendamment de l’âge, du sexe et des comorbidités. Le 2e axe a comparé les profils moteurs observés en MAD-HR entre les volontaires sains et les patients atteints de désordres de l’axe cerveau intestin (DACI), et principalement une dyspepsie fonctionnelle (DF). Les patients avec DACI présentaient une motricité duodénale diminuée pendant la phase II du complexe moteur migrant, avec moins de contractions propagées antro-duodénales. Les données manométriques ont ensuite été corrélées à une mesure concomitante de la vidange gastrique. Nous avons montré qu’en post-prandial, une diminution de fréquence des contractions antrales, et un pylorospasme étaient présents chez respectivement 56% et 32% des patients avec vidange gastrique ralentie. Enfin, le 3e axe évaluait la mesure par notre sonde de l’impédancemétrie duodénale. Nous avons montré que celle-ci était corrélée à la perméabilité intestinale duodénale, évaluée par l’expression des protéines de jonctions serrées. Une diminution de la perméabilité intestinale en impédancemétrie était observée chez les patients avec DF et ceux avec syndrome de l’intestin irritable, en comparaison aux volontaires sains.
- 8 April 2026
- Published by Agence Bibliographique de l'Enseignement Supérieur
Apport de la manométrie antro-pyloro-duodénale haute résolution couplée à l'impédancemétrie dans la physiopathologie des syndromes dyspeptiques.
La manométrie antro-pyloro-duodénale en haute résolution (MAD-HR) permet une exploration fine des contractions gastro-intestinales et leur propagation. Son apport dans l’exploration des troubles moteurs et fonctionnels de la région gastro-duodénale, se manifestant par des syndromes dyspeptiques, a pourtant été peu évalué. Le 1e axe de ce travail s’est focalisé sur l’apport pronostique de la manométrie intestinale. Nous avons montré qu’une dysmotilité de l’intestin grêle était associée à une surmortalité, par rapport aux patients avec une manométrie normale avec un hazard ratio de 2.60 [1.29–6.89] indépendamment de l’âge, du sexe et des comorbidités. Le 2e axe a comparé les profils moteurs observés en MAD-HR entre les volontaires sains et les patients atteints de désordres de l’axe cerveau intestin (DACI), et principalement une dyspepsie fonctionnelle (DF). Les patients avec DACI présentaient une motricité duodénale diminuée pendant la phase II du complexe moteur migrant, avec moins de contractions propagées antro-duodénales. Les données manométriques ont ensuite été corrélées à une mesure concomitante de la vidange gastrique. Nous avons montré qu’en post-prandial, une diminution de fréquence des contractions antrales, et un pylorospasme étaient présents chez respectivement 56% et 32% des patients avec vidange gastrique ralentie. Enfin, le 3e axe évaluait la mesure par notre sonde de l’impédancemétrie duodénale. Nous avons montré que celle-ci était corrélée à la perméabilité intestinale duodénale, évaluée par l’expression des protéines de jonctions serrées. Une diminution de la perméabilité intestinale en impédancemétrie était observée chez les patients avec DF et ceux avec syndrome de l’intestin irritable, en comparaison aux volontaires sains.
- Open Access
- 13 January 2026
- Published by Georg Thieme Verlag KG in Endoscopy International Open
- Vol. 14 (CP)
Treatment of benign biliary strictures with expandable biodegradable stents: Safety and efficacy in a single center
Benign biliary strictures (BBS) are commonly managed by progressive calibration using plastic or metallic stents. Although fully-covered metallic stents (FC-SEMS) enable immediate calibration to a larger diameter compared with plastic stents, they remain prone to migration and use is limited in intrahepatic and peri-hilar strictures. We report on using uncovered expandable bioresorbable stents (BRES) in a series of selected BBS patients. This retrospective monocentric case series included all consecutive patients treated between 2023 and 2024. Patients were highly selected for uncommon situations for which usual stents were not well suited and followed for at least 12 months after the procedure. Technical success, clinical success, and adverse events (AEs) were systematically recorded. Five procedures were performed in five patients with implantation of a total of eight UNITY-B stents. Three patients underwent internalization of an internal-external drainage across a bilio-digestive anastomotic stricture. One patient was treated with retrograde extra-anatomical endoscopic drainage for an anastomotic stricture. One patient underwent calibration of an intrahepatic stricture following radiofrequency of an IPMN-B. Technical success was achieved in all cases (100%), with clinical success observed in 80% of patients. No AEs were observed. Use of bioresorbable UNITY-B stents appears feasible and safe for selected benign biliary strictures, including in intrahepatic locations. Further studies are needed to confirm these preliminary findings.
- 13 January 2026
- Published by Georg Thieme Verlag KG in Endoscopy International Open
- Vol. 14 (CP)
Open AccessTreatment of benign biliary strictures with expandable biodegradable stents: Safety and efficacy in a single center
Benign biliary strictures (BBS) are commonly managed by progressive calibration using plastic or metallic stents. Although fully-covered metallic stents (FC-SEMS) enable immediate calibration to a larger diameter compared with plastic stents, they remain prone to migration and use is limited in intrahepatic and peri-hilar strictures. We report on using uncovered expandable bioresorbable stents (BRES) in a series of selected BBS patients. This retrospective monocentric case series included all consecutive patients treated between 2023 and 2024. Patients were highly selected for uncommon situations for which usual stents were not well suited and followed for at least 12 months after the procedure. Technical success, clinical success, and adverse events (AEs) were systematically recorded. Five procedures were performed in five patients with implantation of a total of eight UNITY-B stents. Three patients underwent internalization of an internal-external drainage across a bilio-digestive anastomotic stricture. One patient was treated with retrograde extra-anatomical endoscopic drainage for an anastomotic stricture. One patient underwent calibration of an intrahepatic stricture following radiofrequency of an IPMN-B. Technical success was achieved in all cases (100%), with clinical success observed in 80% of patients. No AEs were observed. Use of bioresorbable UNITY-B stents appears feasible and safe for selected benign biliary strictures, including in intrahepatic locations. Further studies are needed to confirm these preliminary findings.
- 1 November 2025
- Published by JLE in Journal de Pharmacie Clinique
- Vol. 32 (9) , 907-914
Chronic intestinal pseudo-obstruction: from diagnosis to management
- 1 November 2025
- Published by JLE in Journal de Pharmacie Clinique
- Vol. 32 (9) , 907-914
Chronic intestinal pseudo-obstruction: from diagnosis to management
- Open Access
- 18 June 2025
- Published by Wiley in Neurogastroenterology & Motility
- Vol. 38 (4) , e70098
Consensus on the Management of Anesthetic Agents During Digestive Motility Measurements and Proposal of a Standardized Protocol for Anesthesia (French Neuro Gastroenterology Group GFNG and Committee of Anesthetic French Experts)
Introduction: Techniques for measuring digestive motility are becoming increasingly precise and enable therapeutic interventions. However, while most of these interventions require general anesthesia, there is limited data on the impact of anesthetic agents on these measurements, and no standardized anesthesia protocol currently exists to guide such procedures. Our working group carried out two Delphi processes involving experts in neurogastroenterology and anesthesiology to reach a consensus on which drugs affect these measurements and to establish an anesthesia protocol. Method: Two expert groups were formed, comprising 13 neurogastroenterology experts from the French Neuro‐Gastroenterology Group (GFNG) and 15 full‐ or associate professors in anesthesia and intensive care. The first Delphi process involved the neurogastroenterologists and aimed to identify which anesthetic drugs influenced digestive pressure measurements. The second Delphi process, involving anesthetists, sought to develop an anesthesia protocol. Each expert indicated their level of agreement with each statement using a 6‐point Likert scale. A statement was endorsed when at least 80% of experts agreed with it. The strength of evidence for each statement was evaluated using the GRADE system. Results: The Delphi process with neurogastroenterologists was conducted over three rounds and ultimately resulted in 91 amendments. The second Delphi process with anesthetists took place over two rounds and included 28 amendments, leading to the development of an anesthesia protocol. Conclusion: To our knowledge, this work is the first to establish an expert consensus on anesthetic agents that can affect digestive motility measurements and to propose an anesthesia protocol that accounts for the needs of neurogastroenterologists.
- 18 June 2025
- Published by Wiley in Neurogastroenterology & Motility
- Vol. 38 (4) , e70098
Open AccessConsensus on the Management of Anesthetic Agents During Digestive Motility Measurements and Proposal of a Standardized Protocol for Anesthesia (French Neuro Gastroenterology Group GFNG and Committee of Anesthetic French Experts)
Introduction: Techniques for measuring digestive motility are becoming increasingly precise and enable therapeutic interventions. However, while most of these interventions require general anesthesia, there is limited data on the impact of anesthetic agents on these measurements, and no standardized anesthesia protocol currently exists to guide such procedures. Our working group carried out two Delphi processes involving experts in neurogastroenterology and anesthesiology to reach a consensus on which drugs affect these measurements and to establish an anesthesia protocol. Method: Two expert groups were formed, comprising 13 neurogastroenterology experts from the French Neuro‐Gastroenterology Group (GFNG) and 15 full‐ or associate professors in anesthesia and intensive care. The first Delphi process involved the neurogastroenterologists and aimed to identify which anesthetic drugs influenced digestive pressure measurements. The second Delphi process, involving anesthetists, sought to develop an anesthesia protocol. Each expert indicated their level of agreement with each statement using a 6‐point Likert scale. A statement was endorsed when at least 80% of experts agreed with it. The strength of evidence for each statement was evaluated using the GRADE system. Results: The Delphi process with neurogastroenterologists was conducted over three rounds and ultimately resulted in 91 amendments. The second Delphi process with anesthetists took place over two rounds and included 28 amendments, leading to the development of an anesthesia protocol. Conclusion: To our knowledge, this work is the first to establish an expert consensus on anesthetic agents that can affect digestive motility measurements and to propose an anesthesia protocol that accounts for the needs of neurogastroenterologists.
- 6 May 2025
- Published by Wiley in Neurogastroenterology & Motility
- Vol. 37 (6) , e70055
Empowering the Next Generation of Neurogastroenterology—Welcome yESNM
- 6 May 2025
- Published by Wiley in Neurogastroenterology & Motility
- Vol. 37 (6) , e70055
Empowering the Next Generation of Neurogastroenterology—Welcome yESNM
- Open Access
- 25 February 2025
- Published by Elsevier in Bulletin du Cancer
Constipation induite par les opioïdes : état des lieux et modalités de prise en charge
- 25 February 2025
- Published by Elsevier in Bulletin du Cancer
Open AccessConstipation induite par les opioïdes : état des lieux et modalités de prise en charge
- Open Access
- 18 October 2024
- Published by Elsevier in Clinics and Research in Hepatology and Gastroenterology
- Vol. 48 (9) , 102481
Efficacy of gastric per-oral endoscopic myotomy remains similar after failure of interventional techniques in refractory gastroparesis
- 18 October 2024
- Published by Elsevier in Clinics and Research in Hepatology and Gastroenterology
- Vol. 48 (9) , 102481
Open AccessEfficacy of gastric per-oral endoscopic myotomy remains similar after failure of interventional techniques in refractory gastroparesis
- 1 August 2024
- Published by American Physiological Society in American Journal of Physiology-Gastrointestinal and Liver Physiology
- Vol. 327 (2) , G306-G315
Alterations in gastrointestinal motility assessed by high-resolution antroduodenal manometry in patients with severe disorders of gut-brain interaction
Gastrointestinal dysmotility has been assessed poorly in disorders of gut-brain interaction (DGBI), especially with high-resolution antroduodenal manometry. Plots of DGBI patients showed lower duodenal contractions during phase II regarding amplitude, frequency, and contractile integral/sensor (CI/s) compared with healthy volunteers. A lower frequency of propagated antroduodenal contractions was also reported. Finally, antral CI/s was lower in patients with functional dyspepsia during phase III. Further studies are needed to assess the clinical significance of these alterations.
- 1 August 2024
- Published by American Physiological Society in American Journal of Physiology-Gastrointestinal and Liver Physiology
- Vol. 327 (2) , G306-G315
Alterations in gastrointestinal motility assessed by high-resolution antroduodenal manometry in patients with severe disorders of gut-brain interaction
Gastrointestinal dysmotility has been assessed poorly in disorders of gut-brain interaction (DGBI), especially with high-resolution antroduodenal manometry. Plots of DGBI patients showed lower duodenal contractions during phase II regarding amplitude, frequency, and contractile integral/sensor (CI/s) compared with healthy volunteers. A lower frequency of propagated antroduodenal contractions was also reported. Finally, antral CI/s was lower in patients with functional dyspepsia during phase III. Further studies are needed to assess the clinical significance of these alterations.
- Open Access
- 26 May 2024
- Published by Wiley in Neurogastroenterology & Motility
- Vol. 36 (8) , e14821
Symptoms from the Gastroparesis Cardinal Symptom Index and clinical factors associated with delayed gastric emptying in patients with suspected gastroparesis
Background: The association between upper gastrointestinal symptoms and delayed gastric emptying (GE) shows conflicting results. This study aimed to assess whether the symptoms of the Gastroparesis Cardinal Symptom Index (GCSI) and/or the scores were associated with the result of GE tests and whether they could predict delayed GE.Methods: Patients referred for suspected gastroparesis (GP) were included in a prospective database. Demographical data, medical history, and symptoms of the GCSI score were collected for each patient. A GE scintigraphy was then performed with a 4‐hour recording. Delayed GE was defined as a retention rate ≥ 10% at 4 h.Results: Among 243 patients included in this study, 110 patients (45%) had delayed GE. The mean age (49.9 vs. 41.3 years; p < 0.001) and weight loss (9.4 kg vs. 5.6 kg; p = 0.025) were significantly higher in patients with delayed GE. Patients with diabetes or a history of surgery had a higher prevalence of delayed GE (60% and 78%, respectively) than patients without comorbidity (17%; p < 0.001). The GCSI score was higher in patients with delayed GE (3.06 vs. 2.80; p = 0.045), but no threshold was clinically relevant to discriminate between patients with normal and delayed GE. Only vomiting severity was significantly higher in patients with delayed GE (2.19 vs. 1.57; p = 0.01).Conclusion: GE testing should be considered when there are symptoms such as a higher weight loss, comorbidities (diabetes, and history of surgery associated with GP), and the presence of vomiting. Other symptoms and the GCSI score are not useful in predicting delayed GE.
- 26 May 2024
- Published by Wiley in Neurogastroenterology & Motility
- Vol. 36 (8) , e14821
Open AccessSymptoms from the Gastroparesis Cardinal Symptom Index and clinical factors associated with delayed gastric emptying in patients with suspected gastroparesis
Background: The association between upper gastrointestinal symptoms and delayed gastric emptying (GE) shows conflicting results. This study aimed to assess whether the symptoms of the Gastroparesis Cardinal Symptom Index (GCSI) and/or the scores were associated with the result of GE tests and whether they could predict delayed GE.Methods: Patients referred for suspected gastroparesis (GP) were included in a prospective database. Demographical data, medical history, and symptoms of the GCSI score were collected for each patient. A GE scintigraphy was then performed with a 4‐hour recording. Delayed GE was defined as a retention rate ≥ 10% at 4 h.Results: Among 243 patients included in this study, 110 patients (45%) had delayed GE. The mean age (49.9 vs. 41.3 years; p < 0.001) and weight loss (9.4 kg vs. 5.6 kg; p = 0.025) were significantly higher in patients with delayed GE. Patients with diabetes or a history of surgery had a higher prevalence of delayed GE (60% and 78%, respectively) than patients without comorbidity (17%; p < 0.001). The GCSI score was higher in patients with delayed GE (3.06 vs. 2.80; p = 0.045), but no threshold was clinically relevant to discriminate between patients with normal and delayed GE. Only vomiting severity was significantly higher in patients with delayed GE (2.19 vs. 1.57; p = 0.01).Conclusion: GE testing should be considered when there are symptoms such as a higher weight loss, comorbidities (diabetes, and history of surgery associated with GP), and the presence of vomiting. Other symptoms and the GCSI score are not useful in predicting delayed GE.